MedTrace Logo

Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase

NCT05731661 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2026-01-15

No results posted yet for this study

Summary

While the sequelae and toxicities after ovarian and endometrial cancer treatments are well described in the literature, the actual needs of patients for supportive oncology care remain poorly documented. Moreover, there is no data available to estimate the complexity of the oncological support care actions to be implemented.

It is expected that an evaluation of the needs for supportive oncology care and its organization in day hospitalization for supportive oncology care will lead to an improvement in personalized post-cancer follow-up for these patients and to an improvement in their long-term quality of life.

Conditions

  • Long Term Cancer Side Effects
  • Supportive Care in Cancer
  • Cancer Survivorship Care Plan
  • Advanced Nurse Practitioner
  • Pelvic Gynecological Cancer

Interventions

OTHER

Day hospitalization in support care with meeting with support care professionals and coordination of actions by the advanced practice nurse

During this day hospitalization, patients will meet with different specialized professionals depending on the support care needs identified.

OTHER

Delivery of useful information according to support care needs, concerning support care professionals in the city

Delivery of useful information according to support care needs, concerning support care professionals in the city

OTHER

Delivery of a personalized post-cancer plan

Delivery of a personalized post-cancer plan

Sponsors & Collaborators

  • Ligue contre le cancer, France

    collaborator OTHER

  • Centre Francois Baclesse

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-09
Primary Completion
2025-11-20
Completion
2027-02-25

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05731661 on ClinicalTrials.gov